News
$Tharimmune(THAR.US$ Tharimmune Announces Results In Phase 1 Clinical Trial Of TH104, Compared Oral Transmucosal Delivery Of TH104 To Injectable Reference Approved Drug Completed
Benzinga· 4 mins ago![]()
Benzinga· 4 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
MangoXXXX : What happened with the news?? It dropped
TrytosaveabitOP MangoXXXX: Yup! PM and AM are hard to trade! You don’t get a clear picture of interest and liquidity! GL
102426651 Lambor : no good. trap buyer. many rush to buy. all trap.